Skip to content
sugarisadrug.com
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

Author: sugaradmin

1288-OR: Stakeholder-Guided Design of a Pediatric Type 2 Diabetes Group Education Curriculum

June 9, 2026 by sugaradmin

Introduction and Objective: Effective care models are needed for youth with type 2 diabetes (YT2D). Shared medical appointments using group education modules benefitted youth with T1D. This study aimed to design group education modules called Team Clinic for T2D (TCT2) with input from primarily Latinx, publicly insured YT2D, caregivers, and clinicians.Methods: An iterative human-centered design […]

Read More
DiabetesLeave a Comment on 1288-OR: Stakeholder-Guided Design of a Pediatric Type 2 Diabetes Group Education Curriculum

1299-OR: Concordance of Libre, Dexcom, and Medtronic Glucose Management Indicator (GMI) and Laboratory HbA1c

June 9, 2026 by sugaradmin

Introduction and Objective: A recent study comparing Freestyle Libre (FSL) 3, Dexcom (Dex) G7, and Medtronic (Med) Simplera CGM systems found discordant glycaemic metrics, with Med showing a significantly lower glucose management indicator (GMI) and a higher time-in-range. The purpose of this study was to assess concordance between laboratory HbA1c and GMI from three sensor […]

Read More
DiabetesLeave a Comment on 1299-OR: Concordance of Libre, Dexcom, and Medtronic Glucose Management Indicator (GMI) and Laboratory HbA1c

1280-OR: Association between Preprocedural Glycemia and Adverse Cardiovascular Outcomes following Endovascular Revascularization in Diabetic Patients with Lower Extremity Arteriosclerosis Obliterans

June 9, 2026 by sugaradmin

Introduction and Objective: The association between preprocedural glycemia and major adverse cardiovascular events (MACEs) and major adverse limb events (MALEs) after endovascular revascularization in diabetic patients with lower extremity arteriosclerosis obliterans (LEASO) remains unclear. The aim of this study is to explore the link between preprocedural glycaemic control and the 1-year risk of MACEs and […]

Read More
DiabetesLeave a Comment on 1280-OR: Association between Preprocedural Glycemia and Adverse Cardiovascular Outcomes following Endovascular Revascularization in Diabetic Patients with Lower Extremity Arteriosclerosis Obliterans

1267-OR: Ademaglitazone Improves Whole-Body Insulin Sensitivity while Limiting Adipogenesis and Promoting Neuroprotection in Diet-Induced Diabesity

June 9, 2026 by sugaradmin

Introduction and Objective: “Diabesity,” the coexistence of obesity and type 2 diabetes, is a major global health problem characterized by systemic insulin resistance (IR) and increased risk of neurodegenerative complications. Although thiazolidinedione (TZD) PPAR-γ agonists improve insulin sensitivity, their clinical use is limited by adverse effects including adipogenesis, weight gain, and cardiovascular risk. We developed […]

Read More
DiabetesLeave a Comment on 1267-OR: Ademaglitazone Improves Whole-Body Insulin Sensitivity while Limiting Adipogenesis and Promoting Neuroprotection in Diet-Induced Diabesity

1231-OR: Glucocorticoid Receptor Is Vital for Maternal β-Cell Compensation to Protect against Gestational Diabetes

June 9, 2026 by sugaradmin

Introduction and Objective: Gestational β-cell compensation is an adaptive mechanism by which maternal islets increase insulin secretion to overcome pregnancy-induced insulin resistance. Defective β-cell compensation leads to gestational diabetes mellitus (GDM). We characterized the role of glucocorticoid receptor (GR) in gestational β-cell compensation.Methods: We generated β-cell GR-knockout (βGR-KO) mice, followed by determining the abilities of […]

Read More
DiabetesLeave a Comment on 1231-OR: Glucocorticoid Receptor Is Vital for Maternal β-Cell Compensation to Protect against Gestational Diabetes

1266-OR: Tirzepatide and Pioglitazone Combination Therapy Synergistically Improves Insulin Sensitivity and Adipose Tissue Remodeling

June 9, 2026 by sugaradmin

Introduction and Objective: Tirzepatide, a dual GLP-1 and GIP receptor agonist, enhances glucose-stimulated insulin secretion, significantly reduces HbA1c, and promotes weight loss. Tirzepatide use leads to improvements in insulin sensitivity, both via weight loss-dependent and independent mechanisms. Pioglitazone, a PPARγ activator, enhances insulin sensitivity via distinct pathways. We hypothesized that combining Tirzepatide and pioglitazone would […]

Read More
DiabetesLeave a Comment on 1266-OR: Tirzepatide and Pioglitazone Combination Therapy Synergistically Improves Insulin Sensitivity and Adipose Tissue Remodeling

1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial

June 8, 2026 by sugaradmin

Introduction and Objective: PCSK9 inhibition with evolocumab (evo) decreased CV events in pts at high CV risk w/o a prior MI or stroke in VESALIUS-CV. This pre-specified analysis evaluates the efficacy of evo in pts w/ high-risk diabetes mellitus (HR-DM) for prevention of first CV events.Methods: VESALIUS-CV randomized pts w/ LDL-C ≥90mg/dL and atherosclerosis or […]

Read More
DiabetesLeave a Comment on 1247-OR: Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial

1251-OR: Sustained Effect of a Teaching Kitchen Program for Type 2 Diabetes in Japan: Results from a Randomized Controlled Trial

June 8, 2026 by sugaradmin

Introduction and Objective: To address the unmet need for sustainable lifestyle interventions in type 2 diabetes (T2D), we evaluated the sustained effects of a Teaching Kitchen (TK) program among patients with T2D in Japan.Methods: We conducted a randomized controlled trial with 112 patients (59 men, 53 women) aged 20-79 years with T2D and BMI ≥23 […]

Read More
DiabetesLeave a Comment on 1251-OR: Sustained Effect of a Teaching Kitchen Program for Type 2 Diabetes in Japan: Results from a Randomized Controlled Trial

1232-OR: Dynamic CGM Models to Predict GDM: A GO MOMs Analysis

June 8, 2026 by sugaradmin

Introduction and Objective: In GO MOMS, a multicenter observational study, % time above range (TAR) >134mg/dL, as determined from early pregnancy CGM, added statistically significant but not clinically meaningful predictive value for GDM compared to clinical factors alone. We sought to assess if prediction models incorporating CGM metrics derived from multiple time points improved GDM […]

Read More
DiabetesLeave a Comment on 1232-OR: Dynamic CGM Models to Predict GDM: A GO MOMs Analysis

1243-OR: Novel Montelukast Derivatives for Treating Diabetic Retinopathy

June 8, 2026 by sugaradmin

Introduction and Objective: Early-stage diabetic retinopathy (DR) is characterized by vascular endothelial cell damage and breakdown of the blood-retinal barrier. We and others previously shown that CysLTR1 antagonist Montelukast (MON) is a promising treatment for diabetes-related eye issues. This study aims to develop and assess the effectiveness of new MON derivatives in alleviating endothelial dysfunction […]

Read More
DiabetesLeave a Comment on 1243-OR: Novel Montelukast Derivatives for Treating Diabetic Retinopathy

Posts navigation

Older posts
Newer posts

Recent Posts

  • ‘Ozempic Feet:’ What Causes This Unusual GLP-1 Side Effect?
  • Depo-Provera, IUDs Tied to Higher Brain Tumor Risk
  • Trends in self-reported current diabetes care use, socioeconomic inequalities, and associated factors in Japan: evidence from the Comprehensive Survey of Living Conditions (1986-2022)
  • Bryan Johnson Diagnosed with Autoimmune Gastritis
  • Sam Neill, ‘Jurassic Park’ Star, Dies at 78

Recent Comments

  • A WordPress Commenter on SUCROSE: “PURE” ENERGY AT A PRICE

Archives

  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • November 2024
  • October 2024
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • May 2017

Categories

  • Celebrity Health
  • Diabetes
  • Food Choices
  • Fructose
  • General Sugar
  • Glucose
  • Health News
  • Insulin
  • Mental Health
  • Natural Unrefined Sugar
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Sucrose
  • Sugar Science

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Home
  • Diabetes
  • Health News
  • General Sugar
  • Food Choices
  • Insulin
  • Mental Health
  • Stop Eating Sugar
  • Stop Killing Yourself
  • Fructose
  • Sugar Science

© 2026 Sugar is a DRUG | Sugar Addiction Awareness